摘要
目的:制备靶向人滋养层细胞表面抗原2(human trophoblast cell surface antigen 2,Trop-2)的嵌合抗原受体T细胞(chimeric antigen receptor T cell,CAR-T),观察Trop-2 CAR-T细胞在体外对卵巢癌细胞增殖的影响。方法:运用分子克隆及基因重组技术构建Trop-2 CAR;采用Western blot检测Trop-2 CAR在293T细胞中的表达;CCK-8法检测Trop-2 CAR-T细胞对卵巢癌细胞增殖的影响;ELISA检测细胞因子分泌的变化。结果:酶切鉴定及测序分析结果表明,Trop-2 CAR各基因片段连接正确;Western blot检测结果显示,该质粒能够在293T细胞中有效表达;CCK-8结果显示,制备的Trop-2 CAR-T细胞在体外能明显抑制表达Trop-2的卵巢癌细胞的增殖(P<0.05);ELISA检测结果表明Trop-2 CAR-T细胞与表达Trop-2的卵巢癌细胞共培养后,干扰素(interferon-γ,IFN-γ)、白介素(interleukin-2,IL-2)细胞因子分泌增加(P<0.01)。结论:该研究成功制备了Trop-2 CAR-T细胞,可有效抑制Trop-2表达阳性的卵巢癌细胞的增殖。
Objective: To produce Trop-2-targeted chimeric antigen receptor T cells(CAR-T cells) of human trophoblast cell surface antigen 2(Trop-2) and detect their effects on the proliferation of ovarian cancer cells in vitro. Methods: Molecular cloning and gene recombination technology were introduced to construct Trop-2 CAR vector. The expression of Trop-2 CAR on 293 T cells was tested by Western blot. The effect of Trop-2 CAR-T cells on the proliferation of ovarian cancer cells was evaluated by CCK-8 assay. The secreting changes of cytokines by Trop-2 CAR-T cells were detected by ELISA. Results: The results of enzyme digestion and sequencing demonstrated that the Trop-2 CAR vector was constructed correctly. The results of Western blot showed that Trop-2 CAR was expressed on 293 T cells. The results of CCK-8 verified that Trop-2 CAR-T cells prominently inhibited the growth of ovarian cancer cells with Trop-2 antigen expression(P〈0.05), moreover, higher levels of IFN-γ and IL-2 were detected in supernatant by ELISA(P〈0.01).Conclusion: Trop-2 CAR-T cells were prepared successfully and could inhibit the proliferation of ovarian cancer cells expressing Trop-2 antigen.
作者
徐亚如
周荧
唐奇
刘振云
黄骁辰
杨婷婷
张慧林
赵薇
蒯兴旺
仇镇宁
朱进
冯振卿
Xu Yaru Zhou Ying Tang Qi Liu Zhengyun Huang Xiaochen Yang Tingting Zhang Huilin Zhao Wei Kuai Xingwang Qiu Zhenning Zhu Jin Feng Zhenqing(Department of Pathology, NJMU, Nanjing 211166 Key Laboratory of Antibody Technology, National Health and Family Planning Commission, NJMU, Nanjing 211166 Department of Otolaryngology, the Second Affiliated Hospital of NJMU, Nanjing 210011 Sinobioway Cell Therapy Limited Liability Company, Hefei 238000 Obstetrics and Gynecology Depantment, Naning Maternity and Child Care Hopsital Affiliated to NJMU, Nanjing 210004 Medical Research Institute of Nanjing Military Region, Nanjing 210002, China)
出处
《南京医科大学学报(自然科学版)》
CSCD
北大核心
2017年第6期653-658,共6页
Journal of Nanjing Medical University(Natural Sciences)
基金
国家自然科学基金(81602119)
江苏省科学技术厅重点研发专项基金(BE2016799)